Chesley Taft & Associates’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-8,905
| Closed | -$929K | – | 294 |
|
|
2017
Q4 | $929K | Sell |
8,905
-172,635
| -95% | -$18M | 0.08% | 176 |
|
|
2017
Q3 | $26.5M | Buy |
181,540
+180
| +0.1% | +$26.2K | 2.29% | 5 |
|
|
2017
Q2 | $23.6M | Buy |
181,360
+1,389
| +0.8% | +$180K | 2.13% | 6 |
|
|
2017
Q1 | $22.4M | Sell |
179,971
-852
| -0.5% | -$106K | 2.11% | 7 |
|
|
2016
Q4 | $20.9M | Sell |
180,823
-610
| -0.3% | -$70.6K | 2.07% | 7 |
|
|
2016
Q3 | $19M | Buy |
181,433
+2,878
| +2% | +$301K | 1.91% | 9 |
|
|
2016
Q2 | $17.6M | Buy |
178,555
+33,031
| +23% | +$3.26M | 1.81% | 10 |
|
|
2016
Q1 | $14.6M | Sell |
145,524
-41,690
| -22% | -$4.17M | 1.54% | 16 |
|
|
2015
Q4 | $22.4M | Sell |
187,214
-14,332
| -7% | -$1.72M | 2.36% | 5 |
|
|
2015
Q3 | $21.8M | Buy |
201,546
+5,535
| +3% | +$599K | 2.38% | 5 |
|
|
2015
Q2 | $22.7M | Buy |
196,011
+225
| +0.1% | +$26K | 2.31% | 4 |
|
|
2015
Q1 | $22.6M | Buy |
195,786
+5,710
| +3% | +$658K | 2.32% | 4 |
|
|
2014
Q4 | $21.3M | Buy |
190,076
+350
| +0.2% | +$39.2K | 2.15% | 5 |
|
|
2014
Q3 | $18M | Buy |
189,726
+18,190
| +11% | +$1.72M | 1.88% | 8 |
|
|
2014
Q2 | $14.7M | Buy |
171,536
+166,366
| +3,218% | +$14.3M | 1.52% | 12 |
|
|
2014
Q1 | $361K | Sell |
5,170
-400
| -7% | -$27.9K | 0.04% | 202 |
|
|
2013
Q4 | $471K | Sell |
5,570
-650
| -10% | -$55K | 0.05% | 214 |
|
|
2013
Q3 | $479K | Hold |
6,220
| – | – | 0.05% | 208 |
|
|
2013
Q2 | $364K | Buy |
+6,220
| New | +$364K | 0.04% | 219 |
|